Event Identification

 

Title

Dissemination event on “Sector Analysis and Joint Curriculum on Health Technology Assessment” during XVth Annual Conference “Drug pricing in Europe - fair, uniform or both?”

Description of the multiplier event

During the ISPOR Poland Chapter XVth Annual Conference “Drug pricing in Europe - fair, uniform or both?” on November 30th, 2017 in Warsaw, Poland Warsaw Medical University has organized the meeting for presenting the JoC HTA results. The presentation (attachment no. 1) has been delivered two times: 1. for Polish audience only in Polish at the end of the preconference workshop (11.45) and 2. for international audience in English at the end of panel discussion on the rational medicinal policy in CEE countries (14.30). 26 participants in total were present: 25 from Poland, 1 from Slovakia (see participant list attached – attachment no. 2).

The aim of the meeting was not only to share the information on joint curriculum but as well to gather 1. participant’s opinions about a demand for the MSc in HTA specialists and 2. an information on a potential active MSc in HTA curriculums focused on the needs of CESE countries.  The survey has been proposed to the participants (attachment no. 3); 16 responses has been acquired (14 from Polish participants, 1 – a Greek participant, 1 – a Slovak participant). All responders agreed that the MSc in HTA educational program tailored to the need of CESE countries is needed. As currently active MSc in HTA programs focused at CESE countries the MSc Program in Health Policy, Planning and Financing with the Specialization In Health Economics at Eötvös Loránd University (ELTE), Budapest was indicated; the others mentioned were generic (not specific for CESE countries) MSc programs at Erasmus Univ. (Netherlands), UK Universities, MSc of Health Economics at Univ. of Cologne.

The need for HTA specialists in the company of the responder was estimated to 3-4 people (min. 0, max. 25) in next 5 years an average per (Polish) company. The need for HTA specialists in Poland in next 5 years has been estimated to 30people in average (min.5, max. 100).

The third aim of the meeting was to obtain the oral declarations of a willingness to offer internship placement for JoC MSc in HTA students. Six declarations has been acquired from pharma companies (AstraZeneca Pharma Poland Sp. z o.o, Novartis Poland Sp. z o.o., Abbott Laboratories Poland Sp. z o.o., Biogen Poland Sp. z o.o.), academic institution (Comenius Univ., Faculty of Pharmacy, Bratislava), consultancy  company (MAHTA Sp z o.o.).

Country of venue

POLAND, WARSAW

Start Date (dd-mm-yyyy)

30-11-2017

Start Date (dd-mm-yyyy)

01-12-2017

Intellectual outputs covered (using  Intellectual outputs Identification number)

IO1; IO2

Leading Organization

WARSZAWSKI UNIWERSYTET MEDYCZNY

Participating Organizations

pharma companies (AstraZeneca Pharma Poland Sp. z o.o, Novartis Poland Sp. z o.o., Abbott Laboratories Poland Sp. z o.o., Biogen Poland Sp. z o.o.), academic institution (Comenius Univ., Faculty of Pharmacy, Bratislava), consultancy  company (MAHTA Sp z o.o.).

 

 

Event Identification

 

Title

Dissemination event on “Sector Analysis and Joint Curriculum on Health Technology Assessment” during 12th International Evidence-Based Health Care Symposium titled “HTA: evidence and value in decision-making paradigm”

Description of the multiplier event

During the 12th International Evidence-Based Health Care Symposium titled “HTA: evidence and value in decision-making paradigm” on December 12th, 2017 in Cracow the team of Medical University of Warsaw presented the JoC HTA results. The presentation (attachment no. 1) has been delivered during Session 5th, together with Alan Haycox speech on “Making sense of the evidence – a program for developing enhanced HTA expertise in CEE”. 54 participants in total were present: 50 Polish participants, 1 from Macedonia, 2 from Latvia, 1 from Czech Republic (see participant list attached – attachment no. 2).

The aim of the meeting was not only to share the information on joint curriculum but as well to gather 1. participant’s opinions about a demand for the MSc in HTA specialists and 2. an information on a potential active MSc in HTA curriculums focused on the needs of CESE countries.  The survey has been proposed to the participants (attachment no. 3; the same as at multiplier event on November 30th in Warsaw); 20 responses has been acquired (13 from Polish participants, 2 from both Serbian and Latvian participants, 1 from UK, USA, Canadian participants). All responders agreed that the MSc in HTA educational program tailored to the need of CESE countries is needed. No information on the currently active MSc in HTA programs nor the ones focused at CESE countries has been provided.

The current employment of HTA specialists in the respondent’s company was 46 person in average. The need for HTA specialists in the company of the responder was estimated to 25 people (min. 3, max. 80) in next 5 years in average per company. The need for HTA specialists in respondent’s country in next 5 years has been estimated to 155 people in average (min. 10, max. 750) while the one in CESE countries as a whole to 576 people (min. 10, max. 2000).

The third aim of the meeting was to obtain the oral declarations of a willingness to offer internship placement for JoC MSc in HTA students or to cooperate in the other way. Eight proposals of the cooperation have been obtained.

Country of venue

POLAND

Start Date (dd-mm-yyyy)

11-12-2017

Start Date (dd-mm-yyyy)

12-12-2017

Intellectual outputs covered (using  Intellectual outputs Identification number)

IO1; IO2

Leading Organization

WARSZAWSKI UNIWERSYTET MEDYCZNY

Participating Organizations